Literature DB >> 19519307

Thin, stubby or mushroom: spine pathology in Alzheimer's disease.

C Tackenberg1, A Ghori, R Brandt.   

Abstract

Since their first description by Ramon y Cajal at the end of the 19th century, dendritic spines have been proposed as important sites of neuronal contacts and it has been suggested that changes in the activity of neurons directly affect spine morphology. In fact, since then it has been shown that about 90% of excitatory synapses end on spines. Recent data indicate that spines are highly dynamic structures and that spine shape correlates with the strength of synaptic transmission. Furthermore, several mental disorders including Alzheimer's disease (AD) are associated with spine pathology suggesting that spine alterations play a central role in mental deficits. The aim of this review is to provide an overview about the current knowledge on spine morphology and function as well as about different experimental models to analyze spine changes and dynamics. The second part concentrates on disease-relevant factors that are associated with AD and which lead to spine alterations. In particular, data that provide evidence that Abeta oligomers or fibrillar Abeta deposits influence spine morphology and function will be presented and the contribution of tau pathology will be discussed. The review ends with the discussion of potential mechanisms how disease-relevant factors influence dendritic spines and whether and how spine changes could be therapeutically suppressed or reversed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19519307     DOI: 10.2174/156720509788486554

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  45 in total

1.  Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss.

Authors:  Bonnie G Garcia; M Diana Neely; Ariel Y Deutch
Journal:  Cereb Cortex       Date:  2010-01-29       Impact factor: 5.357

2.  Neuronal Store-Operated Calcium Entry and Mushroom Spine Loss in Amyloid Precursor Protein Knock-In Mouse Model of Alzheimer's Disease.

Authors:  Hua Zhang; Lili Wu; Ekaterina Pchitskaya; Olga Zakharova; Takashi Saito; Takaomi Saido; Ilya Bezprozvanny
Journal:  J Neurosci       Date:  2015-09-30       Impact factor: 6.167

Review 3.  Dendritic vulnerability in neurodegenerative disease: insights from analyses of cortical pyramidal neurons in transgenic mouse models.

Authors:  Jennifer I Luebke; Christina M Weaver; Anne B Rocher; Alfredo Rodriguez; Johanna L Crimins; Dara L Dickstein; Susan L Wearne; Patrick R Hof
Journal:  Brain Struct Funct       Date:  2010-02-24       Impact factor: 3.270

Review 4.  Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders.

Authors:  Teruo Hayashi; Shang-Yi Tsai; Tomohisa Mori; Michiko Fujimoto; Tsung-Ping Su
Journal:  Expert Opin Ther Targets       Date:  2011-03-05       Impact factor: 6.902

5.  Spine pruning in 5xFAD mice starts on basal dendrites of layer 5 pyramidal neurons.

Authors:  Sarah E Crowe; Graham C R Ellis-Davies
Journal:  Brain Struct Funct       Date:  2013-02-17       Impact factor: 3.270

6.  Alterations in synaptic density and myelination in response to exposure to high-energy charged particles.

Authors:  Dara L Dickstein; Ronan Talty; Erin Bresnahan; Merina Varghese; Bayley Perry; William G M Janssen; Allison Sowa; Erich Giedzinski; Lauren Apodaca; Janet Baulch; Munjal Acharya; Vipan Parihar; Charles L Limoli
Journal:  J Comp Neurol       Date:  2018-11-08       Impact factor: 3.215

Review 7.  Dysregulation of neuronal calcium homeostasis in Alzheimer's disease - A therapeutic opportunity?

Authors:  Elena Popugaeva; Ekaterina Pchitskaya; Ilya Bezprozvanny
Journal:  Biochem Biophys Res Commun       Date:  2016-09-15       Impact factor: 3.575

Review 8.  Dendritic spine pathology in neuropsychiatric disorders.

Authors:  Peter Penzes; Michael E Cahill; Kelly A Jones; Jon-Eric VanLeeuwen; Kevin M Woolfrey
Journal:  Nat Neurosci       Date:  2011-03       Impact factor: 24.884

Review 9.  Fragile X Syndrome and Alzheimer's Disease: Another story about APP and beta-amyloid.

Authors:  J S Malter; B C Ray; P R Westmark; C J Westmark
Journal:  Curr Alzheimer Res       Date:  2010-05       Impact factor: 3.498

10.  Divergent pathways mediate spine alterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau.

Authors:  Christian Tackenberg; Roland Brandt
Journal:  J Neurosci       Date:  2009-11-18       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.